{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:16:30Z","timestamp":1784085390298,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1124\/jpet.106.119123","type":"journal-article","created":{"date-parts":[[2007,3,10]],"date-time":"2007-03-10T01:53:16Z","timestamp":1173491596000},"page":"1118-1126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["In Vitro and in Vivo Pharmacological Characterization of Ethyl-4-{trans-4-[((2 S)-2-hydroxy-3-{4-hydroxy-3[(methylsulfonyl)amino]-phenoxy}propyl) Amino]cyclohexyl}benzoate Hydrochloride (SAR150640), a New Potent and Selective Human \u03b23-Adrenoceptor Agonist for the Treatment of Preterm Labor"],"prefix":"10.1016","volume":"321","author":[{"given":"Tiziano","family":"Croci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Rouget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzia","family":"Viviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Guagnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvon","family":"Fradin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pascal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Advenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Breuiller-Fouch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e8phe","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bardou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.106.119123_bib1","doi-asserted-by":"crossref","unstructured":"Ananth CV, Misra DP, Demissie K, and Smulian JC (2001) Rates of preterm delivery among black women and white women in the United States over two decades: an age-period-cohort analysis. Am J Epidemiol 154: 657-665.","DOI":"10.1093\/aje\/154.7.657"},{"key":"10.1124\/jpet.106.119123_bib2","doi-asserted-by":"crossref","unstructured":"Andersson RG, Berg G, Johansson SR, and Ryden G (1980) Effects of non-selective and selective \u03b2-adrenergic agonists on spontaneous contractions and cyclic AMP levels in myometrial strips from pregnant women. Gynecol Obstet Investig 11: 268-293.","DOI":"10.1159\/000299848"},{"key":"10.1124\/jpet.106.119123_bib3","doi-asserted-by":"crossref","unstructured":"Bardou M, Loustalot C, Cortijo J, Simon B, Naline E, Dumas M, Esteve S, Croci T, Chalon P, Frydman R, et al. (2000) Functional, biochemical and molecular biological evidence for a possible \u03b23-adrenoceptor in human near-term myometrium. Br J Pharmacol 130: 1960-1966.","DOI":"10.1038\/sj.bjp.0703491"},{"key":"10.1124\/jpet.106.119123_bib4","doi-asserted-by":"crossref","unstructured":"Berg G, Andersson RG, and Ryden G (1983) In vitro study of phosphodiesterase-inhibiting drugs: a complement to \u03b2-sympathomimetic drug therapy in premature labor? Am J Obstet Gynecol 145: 802-806.","DOI":"10.1016\/0002-9378(83)90682-8"},{"key":"10.1124\/jpet.106.119123_bib5","doi-asserted-by":"crossref","unstructured":"Berg G, Andersson RG, and Ryden G (1985) \u03b2-adrenergic receptors in human myometrium during pregnancy: changes in the number of receptors after betamimetic treatment. Am J Obstet Gynecol 151: 392-396.","DOI":"10.1016\/0002-9378(85)90310-2"},{"key":"10.1124\/jpet.106.119123_bib6","doi-asserted-by":"crossref","unstructured":"Berkman ND, Thorp JM Jr, Lohr KN, Carey TS, Hartmann KE, Gavin NI, Hasselblad V, and Idicula AE (2003) Tocolytic treatment for the management of preterm labor: a review of the evidence. Am J Obstet Gynecol 188: 1648-1659.","DOI":"10.1067\/mob.2003.356"},{"key":"10.1124\/jpet.106.119123_bib7","doi-asserted-by":"crossref","unstructured":"Bloom JD, Dutia MD, Johnson BD, Wissner A, Burns MG, Largis EE, Dolan JA, and Claus TH (1992) Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent \u03b2-adrenergic agonist virtually specific for \u03b23-receptors. A promising antidiabetic and antiobesity agent. J Med Chem 35: 3081-3084.","DOI":"10.1021\/jm00094a025"},{"key":"10.1124\/jpet.106.119123_bib8","doi-asserted-by":"crossref","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248-254.","DOI":"10.1006\/abio.1976.9999"},{"key":"10.1124\/jpet.106.119123_bib9","doi-asserted-by":"crossref","unstructured":"Breuiller M, Rouot B, Leroy MJ, Blot P, Kaplan L, and Ferre F (1987) Adrenergic receptors in inner and outer layers of human myometrium near term: characterization of \u03b2-adrenergic receptor sites by [125I]-iodocyanopindolol binding. Gynecol Obstet Investig 24: 28-37.","DOI":"10.1159\/000298771"},{"key":"10.1124\/jpet.106.119123_bib10","doi-asserted-by":"crossref","unstructured":"Carbonne B, Cabrol D, Clerget MS, and Germain G (1998) Effects of nomegestrol acetate on spontaneous and sulprostone-induced uterine contractions in pregnant cynomolgus monkeys monitored by telemetry. Am J Obstet Gynecol 178: 150-155.","DOI":"10.1016\/S0002-9378(98)70643-X"},{"key":"10.1124\/jpet.106.119123_bib11","doi-asserted-by":"crossref","unstructured":"Carpene C, Galitzky J, Collon P, Esclapez F, Dauzats M, and Lafontan M (1993) Desensitization of \u03b21 and \u03b22, but not \u03b23, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion. J Pharmacol Exp Ther 265: 237-247.","DOI":"10.1016\/S0022-3565(25)38092-4"},{"key":"10.1124\/jpet.106.119123_bib12","doi-asserted-by":"crossref","unstructured":"Cecchi R, Croci T, Boigegrain R, Boveri S, Baroni M, Boccardi G, Guimbard JP, and Guzzi U (1994) Synthesis and \u03b2-adrenergic activity of atypical \u03b2-adrenergic phenylethanolaminotetralin stereoisomers. Eur J Med Chem 29: 259-267.","DOI":"10.1016\/0223-5234(94)90095-7"},{"key":"10.1124\/jpet.106.119123_bib13","doi-asserted-by":"crossref","unstructured":"Chanrachakul B, Matharoo-Ball B, Turner A, Robinson G, Broughton-Pipkin F, Arulkumaran S, and Khan RN (2003) Reduced expression of immunoreactive \u03b22-adrenergic receptor protein in human myometrium with labor. J Clin Endocrinol Metab 88: 4997-5001.","DOI":"10.1210\/jc.2003-030692"},{"key":"10.1124\/jpet.106.119123_bib14","doi-asserted-by":"crossref","unstructured":"Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50)ofan enzymatic reaction. Biochem Pharmacol 22: 3099-3108.","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"10.1124\/jpet.106.119123_bib15","doi-asserted-by":"crossref","unstructured":"Chellman GJ, Bee WH, Resendez JC, Meyer JK, Bernal J, Moddrelle DS, Haluska GJ, and Reinheimer TM (2004) Telemetric uterine contraction model in preterm cynomolgus monkeys. Reprod Toxicol 18: 285-293.","DOI":"10.1016\/j.reprotox.2003.12.002"},{"key":"10.1124\/jpet.106.119123_bib16","doi-asserted-by":"crossref","unstructured":"Dennedy MC, Friel AM, Gardeil F, and Morrison JJ (2001) \u03b23 versus \u03b22 adrenergic agonists and preterm labour: in vitro uterine relaxation effects. Br J Obstet Gynaecol 108: 605-609.","DOI":"10.1111\/j.1471-0528.2001.00147.x"},{"key":"10.1124\/jpet.106.119123_bib17","doi-asserted-by":"crossref","unstructured":"Doheny HC, Lynch CM, Smith TJ, and Morrison JJ (2005) Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes. J Clin Endocrinol Metab 90: 5786-5796.","DOI":"10.1210\/jc.2005-0574"},{"key":"10.1124\/jpet.106.119123_bib18","doi-asserted-by":"crossref","unstructured":"Dodd JM, Crowther CA, Dare MR, and Middleton P (2006) Oral betamimetics for maintenance therapy after threatened preterm labor. Cochrane Database Syst Rev 25: CD003927.","DOI":"10.1002\/14651858.CD003927.pub2"},{"key":"10.1124\/jpet.106.119123_bib19","doi-asserted-by":"crossref","unstructured":"Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delavier-Klutchko C, and Strosberg AD (1989) Molecular characterization of the human \u03b23-adrenergic receptor. Science (Wash DC) 245: 1118-1121.","DOI":"10.1126\/science.2570461"},{"key":"10.1124\/jpet.106.119123_bib20","doi-asserted-by":"crossref","unstructured":"Engelhardt S, Zieger W, Kassubek J, Michel MC, Lohse MJ, and Brodde OE (1997) Tocolytic therapy with fenoterol induces selective down-regulation of \u03b2-adrenergic receptors in human myometrium. J Clin Endocrinol Metab 82: 1235-1242.","DOI":"10.1210\/jc.82.4.1235"},{"key":"10.1124\/jpet.106.119123_bib21","doi-asserted-by":"crossref","unstructured":"Esbenshade TA, Han C, Theroux TL, Granneman JG, and Minneman KP (1992) Coexisting beta-1 and atypical \u03b2-adrenergic receptors cause redundant increases in cyclic AMP in human neuroblastoma cells. Mol Pharmacol 42: 753-759.","DOI":"10.1016\/S0026-895X(25)09137-0"},{"key":"10.1124\/jpet.106.119123_bib22","doi-asserted-by":"crossref","unstructured":"Fisher MH, Amend AM, Bach TJ, Barker JM, Brady EJ, Candelore MR, Carroll D, Cascieri MA, Chiu SH, Deng L, et al. (1998) A selective human \u03b23 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. J Clin Investig 101: 2387-2393.","DOI":"10.1172\/JCI2496"},{"key":"10.1124\/jpet.106.119123_bib23","unstructured":"Germain G, Lopes P, Cabrol D, Barbe MP, Huneau D, Le Hovezec R, and Sureau C (1986) A comparison of uterine motility in the pregnant and non-pregnant cynomolgus monkey (Macaca fascicularis) and pregnant woman: a manometric and electromyographic study. Acta Physiol Hung 67: 95-115."},{"key":"10.1124\/jpet.106.119123_bib24","doi-asserted-by":"crossref","unstructured":"Goldenberg RL and Rouse DJ (1998) Prevention of premature birth. N Engl J Med 339: 313-320.","DOI":"10.1056\/NEJM199807303390506"},{"key":"10.1124\/jpet.106.119123_bib25","doi-asserted-by":"crossref","unstructured":"Gsell S, Eschenhagen T, Kaspareit G, Nose M, Scholz H, Behrens O, and Wieland T (2000) Apparent up-regulation of stimulatory G-protein alpha subunits in the pregnant human myometrium is mimicked by elevated smoothelin expression. FASEB J 14: 17-26.","DOI":"10.1096\/fasebj.14.1.17"},{"key":"10.1124\/jpet.106.119123_bib26","doi-asserted-by":"crossref","unstructured":"Hollenga C, Brouwer F, and Zaagsma J (1991) Differences in functional cyclic AMP compartments mediating lipolysis by isoprenaline and BRL 37344 in four adipocyte types. Eur J Pharmacol 200: 325-330.","DOI":"10.1016\/0014-2999(91)90590-M"},{"key":"10.1124\/jpet.106.119123_bib27","doi-asserted-by":"crossref","unstructured":"Konkar AA, Vansal SS, Shams G, Fraundorfer PF, Zheng WP, Nikulin VI, De Los Angeles J, Fertel RH, Miller DD, and Feller DR (1999) \u03b2-Adrenoceptor subtype activities of trimetoquinol derivatives: biochemical studies on human \u03b2-adrenoceptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 291: 875-883.","DOI":"10.1016\/S0022-3565(24)35179-1"},{"key":"10.1124\/jpet.106.119123_bib28","doi-asserted-by":"crossref","unstructured":"Mathvink RJ, Tolman JS, Chitty D, Candelore MR, Cascieri MA, Colwell LF Jr, Deng L, Feeney WP, Forrest MJ, Hom GJ, et al. (2000) Discovery of a potent, orally bioavailable \u03b23-adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl] amino] ethyl] phenyl]-4-[4-[4(trifluoromethyl) phenyl] thiazol-2-yl]benzenesulfonamide. J Med Chem 43: 3832-3836.","DOI":"10.1021\/jm000286i"},{"key":"10.1124\/jpet.106.119123_bib29","doi-asserted-by":"crossref","unstructured":"Nantel F, Bouvier M, Strosberg AD, and Marullo S (1995) Functional effects of long-term activation on human \u03b22- and \u03b23-adrenoceptor signalling. Br J Pharmacol 114: 1045-1051.","DOI":"10.1111\/j.1476-5381.1995.tb13311.x"},{"key":"10.1124\/jpet.106.119123_bib30","doi-asserted-by":"crossref","unstructured":"Nohara A, Ohmichi M, Koike K, Masumoto N, Kobayashi M, Akahane M, Ikegami H, Hirota K, Miyake A, and Murata Y (1996) The role of mitogen-activated protein kinase in oxytocin-induced contraction of uterine smooth muscle in pregnant rat. Biochem Biophys Res Commun 229: 938-944.","DOI":"10.1006\/bbrc.1996.1905"},{"key":"10.1124\/jpet.106.119123_bib31","doi-asserted-by":"crossref","unstructured":"Ohmichi M, Koike K, Nohara A, Kanda Y, Sakamoto Y, Zhang ZX, Hirota K, and Miyake A (1995) Oxytocin stimulates mitogen-activated protein kinase activity in cultured human puerperal uterine myometrial cells. Endocrinology 136: 2082-2087.","DOI":"10.1210\/endo.136.5.7536662"},{"key":"10.1124\/jpet.106.119123_bib32","doi-asserted-by":"crossref","unstructured":"Papatsonis D, Flenady V, Cole S, and Liley H (2005) Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 20: CD004452.","DOI":"10.1002\/14651858.CD004452.pub2"},{"key":"10.1124\/jpet.106.119123_bib33","doi-asserted-by":"crossref","unstructured":"Ratkowsky DA and Reedy TJ (1986) Choosing near-linear parameters in the four parameters logistic model radioligands and related assays. Biometrics 42: 575-582.","DOI":"10.2307\/2531207"},{"key":"10.1124\/jpet.106.119123_bib34","doi-asserted-by":"crossref","unstructured":"Rouget C, Bardou M, Breuiller-Fouche M, Loustalot C, Qi H, Naline E, Croci T, Cabrol D, Advenier C, and Leroy MJ (2005) \u03b23-Adrenoceptor is the predominant \u03b2-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancy. J Clin Endocrinol Metab 90: 1644-1650.","DOI":"10.1210\/jc.2004-0233"},{"key":"10.1124\/jpet.106.119123_bib35","doi-asserted-by":"crossref","unstructured":"Rouget C, Breuiller-Fouche M, Mercier FJ, Leroy MJ, Loustalot C, Naline E, Frydman R, Croci T, Morcillo EJ, Advenier C, et al. (2004) The human near-term myometrial \u03b23-adrenoceptor but not the \u03b22-adrenoceptor is resistant to desensitisation after sustained agonist stimulation. Br J Pharmacol 141: 831-841.","DOI":"10.1038\/sj.bjp.0705616"},{"key":"10.1124\/jpet.106.119123_bib36","doi-asserted-by":"crossref","unstructured":"Sanborn BM, Ku CY, Shlykov S, and Babich L (2005) Molecular signaling through G-protein-coupled receptors and the control of intracellular calcium in myometrium. J Soc Gynecol Investig 12: 479-487.","DOI":"10.1016\/j.jsgi.2005.07.002"},{"key":"10.1124\/jpet.106.119123_bib37","doi-asserted-by":"crossref","unstructured":"Sennitt MV, Kaumann AJ, Molenaar P, Beeley LJ, Young PW, Kelly J, Chapman H, Henson SM, Berge JM, Dean DK, et al. (1998) The contribution of classical (\u03b21\/2-) and atypical \u03b2-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel \u03b23-adrenoceptor agonists of differing selectivities. J Pharmacol Exp Ther 285: 1084-1095.","DOI":"10.1016\/S0022-3565(24)37506-8"},{"key":"10.1124\/jpet.106.119123_bib38","doi-asserted-by":"crossref","unstructured":"Slattery MM and Morrison JJ (2002) Preterm delivery. Lancet 360: 1489-1497.","DOI":"10.1016\/S0140-6736(02)11476-0"},{"key":"10.1124\/jpet.106.119123_bib39","doi-asserted-by":"crossref","unstructured":"Strosberg AD (1993) Structure, function, and regulation of adrenergic receptors. Protein Sci 2: 1198-1209.","DOI":"10.1002\/pro.5560020802"},{"key":"10.1124\/jpet.106.119123_bib40","doi-asserted-by":"crossref","unstructured":"Tanaka N, Tamai T, Mukaiyama H, Hirabayashi A, Muranaka H, Akahane S, Miyata H, and Akahane M (2001) Discovery of novel N-phenylglycine derivatives as potent and selective \u03b23-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence. J Med Chem 44: 1436-1445.","DOI":"10.1021\/jm000455z"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524338972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524338972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.106.119123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:17:28Z","timestamp":1740003448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524338972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0022356524338972"],"URL":"https:\/\/doi.org\/10.1124\/jpet.106.119123","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vitro and in Vivo Pharmacological Characterization of Ethyl-4-{trans-4-[((2 S)-2-hydroxy-3-{4-hydroxy-3[(methylsulfonyl)amino]-phenoxy}propyl) Amino]cyclohexyl}benzoate Hydrochloride (SAR150640), a New Potent and Selective Human \u03b23-Adrenoceptor Agonist for the Treatment of Preterm Labor","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.106.119123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}